Registration rights granted to Mr. Barber pursuant to his employment agreement; shares registered for resale on Form S-3 filings dated September 11, 2019 and January 8, 2021.
| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Daniel Barber
Also a director
President, Chief Executive Officer and Director
|
50 | Not stated | Not stated | $3,493,559 | |
|
A. Ernest Toth, Jr.
Chief Financial Officer
|
67 |
Since 2020
6 years
|
2020 | $1,323,547 | |
|
Cassie Jung
Chief Operating Officer
|
47 | Not stated | 2004 | Not reported | |
|
Peter Boyd
Chief People Officer
|
60 | Not stated | 2013 | Not reported | |
|
Matthew W. Davis
Chief Development Officer
|
60 | Not stated | 2025 | Not reported | |
|
Matthew Greenhawt
Chief Medical Officer
|
52 | Not stated | 2026 | Not reported | |
|
Sherry Korczynski
Chief Commercial Officer
|
56 | Not stated | 2024 | Not reported | |
|
Thomas A. Zalewski
Chief Legal Officer and Chief Compliance Officer
|
54 |
Since 2026
this year
|
2026 | Not reported | |
|
Melina T. Cioffi
Senior Vice President - Regulatory Affairs
|
43 | Not stated | 2020 | Not reported | |
|
Lori J Braender
Corporate Secretary
Title from the Form 4 dated May 7, 2026
|
Not stated | Not stated | Not stated | $1,348,238 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 24, 2026 · updated by the 8-K of Sep 29, 2026
| Director | On board | Independent | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|
|
Gregory B. Brown, M.D.
Board chair
|
2007
19 years
|
Independent | Lisata Therapeutics, Inc. | $274,641 | |
|
Daniel Barber
CEO
|
2022
4 years
|
Not independent | None stated | Paid as CEO | |
|
John S. Cochran
|
2004
22 years
|
Independent | None stated | $240,919 | |
|
Abigail L. Jenkins
|
2024
2 years
|
Independent | None stated | $200,917 | |
|
Julie Krop, M.D.
|
2021
5 years
|
Independent | None stated | $233,220 | |
|
Marco Taglietti, M.D.
|
2021
5 years
|
Independent | None stated | $213,412 | |
|
Timothy E. Morris
|
2022
4 years
|
Independent | DBV Technologies | $237,612 | |
|
Richard J. Daly
Joined Oct 14, 2026
|
- | Independent | - | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Registration rights granted to Mr. Barber pursuant to his employment agreement; shares registered for resale on Form S-3 filings dated September 11, 2019 and January 8, 2021.
Registration rights granted to these related parties, with pro rata reduction provisions on inclusion in future registered offerings.
Indemnification agreements providing contractual rights to indemnification and expense advancement.
Purchased 91,743 shares of common stock at $1.09 per share and received a warrant for the same number of shares at $0.96 per share in the June 2022 capital funding program.
Purchased 13,761 shares of common stock at $1.09 per share and received a warrant for the same number of shares at $0.96 per share in the June 2022 capital funding program.
Loading...